These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31665212)

  • 41. A Treatment for Refractory High Ileostomy Output.
    Semmens S; Higgins E; Coyne P
    J Pain Palliat Care Pharmacother; 2018; 32(2-3):155-157. PubMed ID: 30395777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Teduglutide in short bowel syndrome patients: A way back to normal life?
    Harpain F; Schlager L; Hütterer E; Dawoud C; Kirchnawy S; Stift J; Krotka P; Stift A
    JPEN J Parenter Enteral Nutr; 2022 Feb; 46(2):300-309. PubMed ID: 34614239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postsurgical Intestinal Rehabilitation Using Semisynthetic Glucagon-Like Peptide-2 Analogue (sGLP-2) at a Referral Center: Can Patients Achieve Parenteral Nutrition and sGLP-2 Independency?
    Solar H; Doeyo M; Ortega M; De Barrio S; Olano E; Moreira E; Buncuga M; Manzur A; Crivelli A; Gondolesi G
    JPEN J Parenter Enteral Nutr; 2021 Jul; 45(5):1072-1082. PubMed ID: 32740966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
    Seidner DL; Fujioka K; Boullata JI; Iyer K; Lee HM; Ziegler TR
    Nutr Clin Pract; 2018 Aug; 33(4):520-527. PubMed ID: 29761915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors and timing of response to teduglutide in patients with short bowel syndrome dependent on parenteral support.
    Chen K; Joly F; Mu F; Kelkar SS; Olivier C; Xie J; Seidner DL
    Clin Nutr ESPEN; 2021 Jun; 43():420-427. PubMed ID: 34024550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of teduglutide in adults with short bowel syndrome-associated intestinal failure.
    Pironi L; Allard JP; Joly F; Geransar P; Genestin E; Pape UF
    Nutr Clin Pract; 2024 Feb; 39(1):141-153. PubMed ID: 37294295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Teduglutide for pediatric short bowel syndrome patients.
    Rosete BE; Wendel D; Horslen SP
    Expert Rev Gastroenterol Hepatol; 2021 Jul; 15(7):727-733. PubMed ID: 33798402
    [No Abstract]   [Full Text] [Related]  

  • 48. Outcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel Syndrome.
    Carter BA; Cohran VC; Cole CR; Corkins MR; Dimmitt RA; Duggan C; Hill S; Horslen S; Lim JD; Mercer DF; Merritt RJ; Nichol PF; Sigurdsson L; Teitelbaum DH; Thompson J; Vanderpool C; Vaughan JF; Li B; Youssef NN; Venick RS; Kocoshis SA
    J Pediatr; 2017 Feb; 181():102-111.e5. PubMed ID: 27855998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
    Jeppesen PB; Sanguinetti EL; Buchman A; Howard L; Scolapio JS; Ziegler TR; Gregory J; Tappenden KA; Holst J; Mortensen PB
    Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intestinal adaptation and rehabilitation in adults with short bowel syndrome.
    Pironi L
    Curr Opin Clin Nutr Metab Care; 2024 Sep; 27(5):457-461. PubMed ID: 38963563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased intestinal absorption in the era of teduglutide and its impact on management strategies in patients with short bowel syndrome-associated intestinal failure.
    Seidner DL; Schwartz LK; Winkler MF; Jeejeebhoy K; Boullata JI; Tappenden KA
    JPEN J Parenter Enteral Nutr; 2013 Mar; 37(2):201-11. PubMed ID: 23343999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nutritional management of a patient with chronic intestinal failure and hemodialysis receiving teduglutide: A case report.
    Florencio Ojeda L; Domínguez Rabadán R; Laínez López M; Jaldón Hidalgo G; Rodríguez Andrés N; Penco Ramírez C; Rebollo Pérez MI
    Nutrition; 2023 Sep; 113():112137. PubMed ID: 37481817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short bowel syndrome: highlights of patient management, quality of life, and survival.
    Kelly DG; Tappenden KA; Winkler MF
    JPEN J Parenter Enteral Nutr; 2014 May; 38(4):427-37. PubMed ID: 24247092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study.
    Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
    Clin Nutr; 2020 Aug; 39(8):2479-2486. PubMed ID: 31784300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Is there life after teduglutide?].
    Martínez Martínez AL; Calles Romero LA; Etxeberría Martín E; Monasterio Jiménez O; Zabalegui Eguinoa A; Paja Fano M; Monzón Mendiolea A; Cadenas González A; Cabriada Nuno JL; Iglesias Hernández NC
    Nutr Hosp; 2020 Jul; 34(3):631-635. PubMed ID: 32406744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of American teduglutide consumers from 2015 to 2020: A large database study.
    Loutfy A; Kurin M; Shah R; Davitkov P
    JPEN J Parenter Enteral Nutr; 2022 Mar; 46(3):646-651. PubMed ID: 34291485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. De Novo Development of Distal Jejunal and Duodenal Adenomas After 41 Months of Teduglutide Treatment in a Patient With Short-Bowel Syndrome: A Case Report.
    Pevny S; Pape UF; Elezkurtaj S; Rieger A; Jürgensen C; Blüthner E; Jochum C; Tacke F; Maasberg S
    JPEN J Parenter Enteral Nutr; 2021 Mar; 45(3):652-656. PubMed ID: 32740933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring.
    de Dreuille B; Cazals-Hatem D; Ronot M; Theou-Anton N; Dermine S; Le Beyec-Le Bihan J; Billiauws L; Le Gall M; Bado A; Joly F
    Am J Clin Nutr; 2023 Jun; 117(6):1143-1151. PubMed ID: 37270288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Teduglutide-Stimulated Intestinal Adaptation Is Complemented and Synergistically Enhanced by Partial Enteral Nutrition in a Neonatal Piglet Model of Short Bowel Syndrome.
    Naberhuis JK; Deutsch AS; Tappenden KA
    JPEN J Parenter Enteral Nutr; 2017 Jul; 41(5):853-865. PubMed ID: 26304601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Teduglutide for the treatment of short bowel syndrome.
    Jeppesen PB
    Drugs Today (Barc); 2013 Oct; 49(10):599-614. PubMed ID: 24191254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.